Quantcast Glaxosmithkline Plc And Genmab A/S Announce Positive Top-Line Results From Pivotal - Congoo
Glaxosmithkline Plc and Genmab A/S Announce Positive Top-Line Results From Pivotal
Have an interest in this Story?
Sign Up for Real-Time email updates
Reuters UK  | May 29, 2013

6:16pm BST Genmab A/S and Glaxosmithkline Plc announced that their Phase III study of ARZERRA (ofatumumab) in combination with chlorambucil versus chlorambucil alone in patients with previously untreated chronic lymphocytic leukemia (CLL) met its primary endpoint of progression free survival (PFS) a...
Read Full Article   
Leave a Comment: You must be logged in to leave a comment     Log in | Register

Featured Members
Lucill Alkabir Lucill Alkabir
Your Canadian Real Estate Connection in Tucson, AZ
Real Estate Industry
Sergio Waldeck, MBA Sergio Waldeck, MBA
Director of Financial Planning and Analysis

  View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2014 Congoo.com. All Rights Reserved.